Enediyne

Last updated
Endiine cis.svg
The enediyne functional group
Calicheamicin.png
Calicheamicin: An antitumor antibiotic featuring an enediyne unit

Enediynes are organic compounds containing two triple bonds and one double bond.

Contents

Enediynes are most notable for their limited use as antitumor antibiotics (known as enediyne anticancer antibiotics). [1] They are efficient at inducing apoptosis in cells, but cannot differentiate cancerous cells from healthy cells. Consequently, research is being conducted to increase the specificity of enediyne toxicity.

Structure and reactivity

A nine- or ten-membered ring containing a double bond between two triple bonds is termed the warhead of the enediyne. In this state, the warhead is inactive. Enediynes are triggered into a chemically active state via Bergman or Myers-Saito cyclization. The triggering mechanism can be attributed to an intramolecular nucleophilic attack initiated by one of the variable regions of the molecule. Triggering can also occur via attack by an external nucleophile.[ citation needed ]

Bergman cyclization restructures the enediyne ring into two smaller rings. One electron from each of the enediyne triple bonds is pushed to the adjacent single bonds, generating two new double bonds. Meanwhile, another pair of electrons (one from each alkyne) is used form a new covalent bond. The resulting formation is a 1,4-benzenoid diradical fused to a ring composed of the leftover atoms from the original enediyne.

Electron pushing that occurs during Bergman cyclization in a generic enediyne molecule. A 1,4-benzenoid diradical fused to another ring is the result. Generic Bergman Cyclization Electron Movement.png
Electron pushing that occurs during Bergman cyclization in a generic enediyne molecule. A 1,4-benzenoid diradical fused to another ring is the result.

Some enediynes have an epoxide group attached to their ring, making Bergman cyclization unfavorable due to steric hindrance. For Bergman cyclization to occur, the epoxide must be removed.

Myers-Saito cyclization is another triggering mechanism by which an enediyne warhead becomes a diradical. This mechanism requires the alkene of the enediyne to be part of a diene with a double bond in a variable group. A nucleophile will attack the double bond in the variable region, causing a chain reaction of electron pushing. Ultimately, one of the triple bonds of the enediyne is converted to a cumulene. [2] The cumulene and the remaining alkyne donate one electron each to form a new covalent bond.

A generic enediyne molecule is pictured above. During Myers-Saito cyclization, electrons pushing begins at the diene and generates an unstable cumulene. This cumulene and the nearby alkyne donate one electron to split the enediyne ring into two fused rings. Generic Myers-Saito Cyclization Movement.png
A generic enediyne molecule is pictured above. During Myers-Saito cyclization, electrons pushing begins at the diene and generates an unstable cumulene. This cumulene and the nearby alkyne donate one electron to split the enediyne ring into two fused rings.

The diradicals generated by Bergman and Myers-Saito cyclization are highly reactive.[ citation needed ]

Mechanism of action

Abstraction of hydrogen from either the C1, C4, or C5 position of the sugar phosphate backbone of DNA by a reactive 1,4-benzenoid Enediyne DNA damage.png
Abstraction of hydrogen from either the C1, C4, or C5 position of the sugar phosphate backbone of DNA by a reactive 1,4-benzenoid

The cyclization of the enediyne functional group creates a transient reactive 1,4-benzenoid diradical that acts as a nucleophile and attacks electrophiles in order to achieve a more stable form. In biological systems, once the diradical is positioned in the minor groove of double-stranded DNA, it abstracts two hydrogen atoms from the sugars opposite strands at either the C1, C4, or C5 positions. [3] The DNA radicals that form can then cause interstrand crosslinks or react with O2, leading to double- or single-stranded DNA cleavage. [4]

Biosynthesis

Members of the enediyne family all share a unique enediyne core that is the cause of their potent cytotoxicity. [5] The enediyne cores are derived from linear, probably polyketide, precursors that consist of seven or eight head-to-tail coupled acetate units. Enediyne assembly involves a highly conserved, iterative type I polyketide synthase (PKS) pathway [6] Sequencing of enediyne gene clusters has confirmed the polyketide origin of the enediyne core, and elucidated the biosynthetic pathways and mechanisms of enediynes. [7]

Differences in the biosynthetic pathways of enediynes are due to the different origins of the -yne carbons as well as differences in isotope incorporation patterns. More differentiation comes from the attachment of various functional groups at different positions to the enediyne warheads during their maturation stage. These moieties can be either aromatic or sugars and define sequence specificity of DNA binding as well as the physical properties of the enediyne chromophores. [5]

Due to the cytotoxicity of the enediyne chromophores, their biosynthesis is tightly regulated, although the regulatory mechanisms are still largely unclear. Organisms that produce enediynes have been shown to protect themselves with a self-resistance mechanism that uses a self-sacrificing protein. Notably, some microbes use CalC to sequester calicheamicin so that the reactive diradical abstracts hydrogens from a glycine inside of the protein instead of from DNA. [5]

Classes

There are fourteen naturally occurring enediynes. [6] The other existing classes of enediynes have been synthesized in the lab.

Enediynes have been split into two sub-families: those with nine members in the core enediyne ring and those with ten-membered rings.[ citation needed ]

Nine-membered rings (chromoproteins)

The nine-membered enediynes are also referred to as chromoproteins because they have an attached protein as a variable group. This protein is necessary for transport and stabilization of the enediyne group. [8]

Neocarzinostatin

Neocarzinostatin is a natural product of Streptomyces carzinostaticus. It forms an apoprotein with a 113-amino acid polypeptide which can cleave histone protein H1. [9] Neocarzinostatin is an example of an enediyne that undergoes triggering via Myers-Saito cyclization. An analog of neocarzinostatin, SMANCS, has been approved for use in Japan as an antitumor drug for liver cancer. [10]

C-1027

Also known as lidamycin, C-1027 is one of the most potent antitumor enediynes. C-1027 was first isolated from Streptomyces globisporus in a soil sample taken from the Qian-Jiang District of China. Unlike most enediynes, C-1027 does not undergo a triggering process to become an activated 1,4-benzenoid diradical. [11] C-1027 has demonstrated potential efficacy against hypoxic tumors. [4]

Ten-membered rings

Calicheamicins

The calicheamicins are a sub-family of enediynes that were isolated from Micromonospora echinospora calichensis. [12] All calicheamicin family members demonstrate potent antimicrobial activity against Gram-positive and Gram-negative organisms. [12] Calicheamicin γ1 exhibited significant antitumor activity against leukemia and melanoma cells in vivo. [12] The calicheamicins are notably similar in structure to the esperamicins.

Esperamicins

The esperamicins are a sub-family of enediynes that are considered among the most potent antitumor antibiotics discovered. [13] First isolated in Actinomadura verrucosospora, members of the esperamicin family include esperamicin A1, A1b, A2, A3, A4, B1, B2, and X. Esperamicin X is an inactive esperamicin naturally produced by A. verrucosospora. [13] Compounds with thiol groups induce triggering among the esperamicins. [14]

Dynemicins

The dynemicins are a sub-family of enediynes whose members are organic compounds generated in Micromonospora chersina. [8] Dynemicin A was the first member of this sub-family to be discovered. It was isolated from M. chersina in a soil sample taken from the state of Gujarat in India. [15] Dynemicins are violet in color because they contain anthraquinone as a variable group attached to the enediyne core. [8] Dynemycins have demonstrated strong antitumor activity against leukemia and melanoma cells. [16]

Golfomycin A

Golfomycin A is a synthetic enediyne molecule designed in an attempt to create a more easily manufactured antitumor antibiotic. [17] DNA strand-scission induced by golfomycin A is pH dependent. [17] Preliminary in vitro studies have demonstrated that golfomycin A can reduce carcinomas in bladder cells. [17]

See also

Related Research Articles

<i>Micromonospora</i> Genus of bacteria

Micromonospora is a genus of bacteria of the family Micromonosporaceae. The genus name was first proposed in 1923 by Danish physician Jeppe Ørskov in an attempt to classify what at the time was considered "ray fungi" based on morphology. Members of this genus are found throughout natural soil and sediment environments, as well as in association with roots of plants of various species. The genus is well known for its ability to produce a variety of medically relevant products.

Aromatization is a chemical reaction in which an aromatic system is formed from a single nonaromatic precursor. Typically aromatization is achieved by dehydrogenation of existing cyclic compounds, illustrated by the conversion of cyclohexane into benzene. Aromatization includes the formation of heterocyclic systems.

<span class="mw-page-title-main">Bergman cyclization</span>

The Masamune-Bergman cyclization or Masamune-Bergman reaction or Masamune-Bergman cycloaromatization is an organic reaction and more specifically a rearrangement reaction taking place when an enediyne is heated in presence of a suitable hydrogen donor. It is the most famous and well-studied member of the general class of cycloaromatization reactions. It is named for Japanese-American chemist Satoru Masamune and American chemist Robert G. Bergman. The reaction product is a derivative of benzene.

<span class="mw-page-title-main">Platensimycin</span> Chemical compound

Platensimycin, a metabolite of Streptomyces platensis, is an antibiotic, which act by blocking enzymes.

<span class="mw-page-title-main">Neocarzinostatin</span> Chemical compound

Neocarzinostatin (NCS) is a macromolecular chromoprotein enediyne antitumor antibiotic secreted by Streptomyces macromomyceticus.

<span class="mw-page-title-main">Calicheamicin</span> Chemical compound

The calicheamicins are a class of enediyne antitumor antibiotics derived from the bacterium Micromonospora echinospora, with calicheamicin γ1 being the most notable. It was isolated originally in the mid-1980s from the chalky soil, or "caliche pits", located in Kerrville, Texas. The sample was collected by a scientist working for Lederle Labs. It is extremely toxic to all cells and, in 2000, a CD33 antigen-targeted immunoconjugate N-acetyl dimethyl hydrazide calicheamicin was developed and marketed as targeted therapy against the non-solid tumor cancer acute myeloid leukemia (AML). A second calicheamicin-linked monoclonal antibody, inotuzumab ozogamicin an anti-CD22-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration on August 17, 2017, for use in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Calicheamicin γ1 and the related enediyne esperamicin are the two of the most potent antitumor agents known.

Robert George Bergman is an American chemist. He is Professor of the Graduate School and Gerald E. K. Branch Distinguished Professor Emeritus at the University of California, Berkeley.

<span class="mw-page-title-main">Indolocarbazole</span> Class of chemical compounds

Indolocarbazoles (ICZs) are a class of compounds that are under current study due to their potential as anti-cancer drugs and the prospective number of derivatives and uses found from the basic backbone alone. First isolated in 1977, a wide range of structures and derivatives have been found or developed throughout the world. Due to the extensive number of structures available, this review will focus on the more important groups here while covering their occurrence, biological activity, biosynthesis, and laboratory synthesis.

Micromonospora echinospora is a species of bacteria that is known for producing the enediyne antibiotic calicheamicins.

<span class="mw-page-title-main">Sporolides</span> Chemical compound

Sporolides A and B are polycyclic macrolides extracted from the obligate marine bacterium Salinispora tropica, which is found in ocean sediment. They are composed of a chlorinated cyclopenta[a]indene ring and a cyclohexenone moiety. They were the second group of compounds isolated from Salinispora, and were said to indicate the potential of marine actinomycetes as a source of novel secondary metabolites. The structures and absolute stereochemistries of both metabolites were elucidated using a combination of NMR spectroscopy and X-ray crystallography.

<span class="mw-page-title-main">Dynemicin A</span> Anti-cancer drug

Dynemicin A is an anti-cancer enediyne drug. It displays properties which illustrate promise for cancer treatments, but still requires further research.

2-Amino-4-deoxychorismate dehydrogenase is an enzyme with systematic name (2S)-2-amino-4-deoxychorismate:FMN oxidoreductase. This enzyme catalyses the following chemical reaction

2-amino-4-deoxychorismate synthase is an enzyme with systematic name (2S)-2-amino-4-deoxychorismate:2-oxoglutarate aminotransferase. This enzyme catalyses the following chemical reaction

Free radical damage to DNA can occur as a result of exposure to ionizing radiation or to radiomimetic compounds. Damage to DNA as a result of free radical attack is called indirect DNA damage because the radicals formed can diffuse throughout the body and affect other organs. Malignant melanoma can be caused by indirect DNA damage because it is found in parts of the body not exposed to sunlight. DNA is vulnerable to radical attack because of the very labile hydrogens that can be abstracted and the prevalence of double bonds in the DNA bases that free radicals can easily add to.

<span class="mw-page-title-main">Anthracimycin</span> Polyketide

Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria. In preliminary laboratory research, it has shown activity against Bacillus anthracis, the bacteria that causes anthrax, and against methicillin-resistant Staphylococcus aureus (MRSA).

<span class="mw-page-title-main">Kedarcidin</span> Chemical compound

Kedarcidin is a chromoprotein antitumor antibiotic first isolated from an Actinomycete in 1992, comprising an ansa-bridged enediyne chromophore (shown) as well as an apoprotein that serves to stabilize the toxin in the Actinomycete. Like other members of the enediyne class of drugs—so named for the nine-or-ten-membered core structure bearing an alkene directly attached to two alkynyl appendages—kedarcidin was likely evolved to kill bacteria that compete with the producing organism. Because it achieves this by causing DNA damage, however, kedarcidin is capable of harming tumor cells, as well. Kedarcidin is thus the subject of scientific research, both for its structural complexity as well as its anticancer properties.

<span class="mw-page-title-main">C-1027</span> Chemical compound

C-1027 or lidamycin is an antitumor antibiotic consisting of a complex of an enediyne chromophore and an apoprotein. It shows antibiotic activity against most Gram-positive bacteria. It is one of the most potent cytotoxic molecules known, due to its induction of a higher ratio of DNA double-strand breaks than single-strand breaks.

<span class="mw-page-title-main">Shishijimicin A</span> Chemical compound

Shishijimicin A is an enediyne antitumor antibiotic isolated from Didemnum proliferum. Isolated in 2003 it is part of the family of 10 member ringed enediyne antitumor antibiotic agents, which includes: namenamicin, esperamicin and, calicheamicin. Due to its high potency from cytotoxicity, Shishjimicin A is currently undergoing testing as a possible Antibody-antibiotic Conjugate (ADCs) cancer treatment. Laboratory tests indicate it to be “more than 1,000 times as toxic to cancer cells as the anticancer drug taxol”, also known as Paclitaxel, a prevalent chemotherapy medication. As such, theoretically, only an administration of a minuscule dose of the molecule would be necessary per each treatment. As shishjimicin A supply is scarce and the full extent of its side effects is not yet established, there is still a need for further biological and clinical studies.

Fostriecin is a type I polyketide synthase (PKS) derived natural product, originally isolated from the soil bacterium Streptomyces pulveraceus. It belongs to a class of natural products which characteristically contain a phosphate ester, an α,β-unsaturated lactam and a conjugated linear diene or triene chain produced by Streptomyces. This class includes structurally related compounds cytostatin and phoslactomycin. Fostriecin is a known potent and selective inhibitor of protein serine/threonine phosphatases, as well as DNA topoisomerase II. Due to its activity against protein phosphatases PP2A and PP4 which play a vital role in cell growth, cell division, and signal transduction, fostriecin was looked into for its antitumor activity in vivo and showed in vitro activity against leukemia, lung cancer, breast cancer, and ovarian cancer. This activity is thought to be due to PP2A's assumed role in regulating apoptosis of cells by activating cytotoxic T-lymphocytes and natural killer cells involved in tumor surveillance, along with human immunodeficiency virus-1 (HIV-1) transcription and replication.

<span class="mw-page-title-main">Metalloenediynes</span>

Metalloenediynes are a family of compounds composed of an enediyne-containing ligand complexed to a transition metal that have potential use as anti-tumor therapeutics. Enediynes naturally undergo the Bergman cyclization to produce a 1,4-didehydrobenzene intermediate, whose thermal activation energy is stabilized by chelation of the ligand to a metal center, allowing for temperature regulation of this diradical formation.

References

  1. ↑ Nicolaou KC, Smith AL, Yue EW (July 1993). "Chemistry and biology of natural and designed enediynes". Proceedings of the National Academy of Sciences of the United States of America. 90 (13): 5881–8. Bibcode:1993PNAS...90.5881N. doi: 10.1073/pnas.90.13.5881 . PMC   46830 . PMID   8327459.
  2. ↑ "Bergman Cyclization". www.organic-chemistry.org. Retrieved 2018-05-05.
  3. ↑ Smith AL, Nicolaou KC (May 1996). "The enediyne antibiotics". Journal of Medicinal Chemistry. 39 (11): 2103–17. doi:10.1021/jm9600398. PMID   8667354.
  4. 1 2 Chen Y, Yin M, Horsman GP, Shen B (March 2011). "Improvement of the enediyne antitumor antibiotic C-1027 production by manipulating its biosynthetic pathway regulation in Streptomyces globisporus". Journal of Natural Products. 74 (3): 420–4. doi:10.1021/np100825y. PMC   3064734 . PMID   21250756.
  5. 1 2 3 Liang ZX (April 2010). "Complexity and simplicity in the biosynthesis of enediyne natural products". Natural Product Reports. 27 (4): 499–528. doi:10.1039/b908165h. PMID   20336235.
  6. 1 2 Shen B, Hindra, Yan X, Huang T, Ge H, Yang D, Teng Q, Rudolf JD, Lohman JR (January 2015). "Enediynes: Exploration of microbial genomics to discover new anticancer drug leads". Bioorganic & Medicinal Chemistry Letters. 25 (1): 9–15. doi:10.1016/j.bmcl.2014.11.019. PMC   4480864 . PMID   25434000.
  7. ↑ Van Lanen SG, Shen B (2008). "Biosynthesis of enediyne antitumor antibiotics". Current Topics in Medicinal Chemistry. 8 (6): 448–59. doi:10.2174/156802608783955656. PMC   3108100 . PMID   18397168.
  8. 1 2 3 Gao Q, Thorson JS (May 2008). "The biosynthetic genes encoding for the production of the dynemicin enediyne core in Micromonospora chersina ATCC53710". FEMS Microbiology Letters. 282 (1): 105–14. doi:10.1111/j.1574-6968.2008.01112.x. PMC   5591436 . PMID   18328078.
  9. ↑ Heyd B, Lerat G, Adjadj E, Minard P, Desmadril M (April 2000). "Reinvestigation of the proteolytic activity of neocarzinostatin". Journal of Bacteriology. 182 (7): 1812–8. doi:10.1128/jb.182.7.1812-1818.2000. PMC   101862 . PMID   10714984.
  10. ↑ Maeda H (March 2001). "SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy". Advanced Drug Delivery Reviews. 46 (1–3): 169–85. doi:10.1016/s0169-409x(00)00134-4. PMID   11259839.
  11. ↑ Xu YJ, Zhen YS, Goldberg IH (May 1994). "C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage". Biochemistry. 33 (19): 5947–54. doi:10.1021/bi00185a036. PMID   8180224.
  12. 1 2 3 Maiese WM, Lechevalier MP, Lechevalier HA, Korshalla J, Kuck N, Fantini A, Wildey MJ, Thomas J, Greenstein M (April 1989). "Calicheamicins, a novel family of antitumor antibiotics: taxonomy, fermentation and biological properties". The Journal of Antibiotics. 42 (4): 558–63. doi: 10.7164/antibiotics.42.558 . PMID   2722671.
  13. 1 2 Golik J, Clardy J, Dubay G, Groenewold G, Kawaguchi H, Konishi M, Krishnan B, Ohkuma H, Saitoh K (May 1987). "Esperamicins, a novel class of potent antitumor antibiotics. 2. Structure of esperamicin X". Journal of the American Chemical Society. 109 (11): 3461–3462. doi:10.1021/ja00245a048. ISSN   0002-7863.
  14. ↑ Sugiura Y, Uesawa Y, Takahashi Y, Kuwahara J, Golik J, Doyle TW (October 1989). "Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics". Proceedings of the National Academy of Sciences of the United States of America. 86 (20): 7672–6. Bibcode:1989PNAS...86.7672S. doi: 10.1073/pnas.86.20.7672 . PMC   298132 . PMID   2813351.
  15. ↑ Konishi M, Ohkuma H, Matsumoto K, Tsuno T, Kamei H, Miyaki T, Oki T, Kawaguchi H, VanDuyne GD, Clardy J (September 1989). "Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit". The Journal of Antibiotics. 42 (9): 1449–52. doi: 10.7164/antibiotics.42.1449 . PMID   2793600.
  16. ↑ Unno R, Michishita H, Inagaki H, Suzuki Y, Baba Y, Jomori T, Nishikawa T, Isobe M (May 1997). "Synthesis and antitumor activity of water-soluble enediyne compounds related to dynemicin A". Bioorganic & Medicinal Chemistry. 5 (5): 987–99. doi:10.1016/s0968-0896(97)00037-0. PMID   9208107.
  17. 1 2 3 Nicolaou KC, Skokotas G, Furuya S, Suemune H, Nicolaou DC (September 1990). "Golfomycin A, a Novel Designed Molecule with DNA-Cleaving Properties and Antitumor Activity". Angewandte Chemie International Edition in English. 29 (9): 1064–1067. doi:10.1002/anie.199010641. ISSN   0570-0833.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.